These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3188960)

  • 1. A quantitative method for evaluating the effects of drugs on bone marrow cellularity using the same experimental animal. Quantification of the effects of a single dose of busulphan.
    Malgor LA; Barrios L; Torales PR; de Albarenque MV; Verges E
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):181-92. PubMed ID: 3188960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of haemopoietic and microenvironmental populations of mouse bone marrow after treatment with busulphan.
    Molineux G; Testa NG; Massa G; Schofield R
    Biomed Pharmacother; 1986; 40(6):215-20. PubMed ID: 3539222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulopoiesis in long-term culture by marrow from mice with busulfan-induced chronic latent aplasia.
    Boyd RL; Caro J; Halka KG; Erslev AJ
    Int J Cell Cloning; 1986 Sep; 4(5):357-67. PubMed ID: 3772175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoiesis, but not thrombocytopoiesis, is affected by the presence of a large amount of subcutaneously implanted bone marrow.
    Ebbe S; Maurer H
    Exp Hematol; 1994 Sep; 22(10):1011-5. PubMed ID: 8088375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic chemotherapy myelosuppression: mechanisms and new approaches.
    Gale RP
    Exp Hematol; 1985; 13 Suppl 16():3-7. PubMed ID: 3987837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemical and biological properties of busulphan ("Myleran").
    Dunn CD
    Exp Hematol; 1974; 2(3):101-17. PubMed ID: 4616840
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
    Basch RS; Quito FL; Beh J; Hirst JA
    Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.
    Maher J; Colonna F; Baker D; Luzzatto L; Roberts I
    Exp Hematol; 1994 Jan; 22(1):8-12. PubMed ID: 8282064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of hematopoiesis in mice treated with busulphan or nitrogen mustard.
    Anderson RW; Matthews KI; Crouse DA; Sharp JG
    Biomed Pharmacother; 1982; 36(3):149-52. PubMed ID: 7150708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxic effects of busulfan on normal and activated hemopoiesis in rats].
    Massa G; Bogliolo G; Ronco R; Dolcino G; Testa R; Pannacciulli I
    Arch Maragliano Patol Clin; 1973; 29(2):143-7. PubMed ID: 4808339
    [No Abstract]   [Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential analysis of animal bone marrow by flow cytometry.
    Martin RA; Brott DA; Zandee JC; McKeel MJ
    Cytometry; 1992; 13(6):638-43. PubMed ID: 1451595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cells in the hereditarily anemic Belgrade laboratory (b/b) rat.
    Ivanović Z; Milenković P; Vasiljevska M; Dekić M
    Exp Hematol; 1995 Oct; 23(11):1218-23. PubMed ID: 7556533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.